Everence Capital Management’s Innoviva INVA Stock Holding History
Bought
Maintained
Sold
Other funds holding INVA
VPM
VCM
SCM
SFM
Everence Capital Management's INVA Position: Q1 2026 in Review
Everence Capital Management reduced its Innoviva (INVA) stake by 18% in Q1 2026, selling an estimated $41.6K and leaving 9,029 shares worth $210K. The position accounts for 0.01% of the portfolio, ranked #738.
Everence Capital Management first reported a position in INVA in Q1 2020 and has held it in 25 quarters since. The position peaked at $232K in Q1 2022. 286 funds tracked by Wall St. Rank hold INVA as of Q1 2026.
- Everence Capital Management held 9,029 shares of Innoviva worth $210K as of Q1 2026.
- Everence Capital Management sold 1,931 Innoviva shares in Q1 2026, an estimated $41.6K.
- Innoviva made up 0.01% of Everence Capital Management's portfolio in Q1 2026, its #738 holding.
- Everence Capital Management first reported a position in Innoviva in Q1 2020 and has held it in 25 quarters since.
- Everence Capital Management's Innoviva position peaked at $232K in Q1 2022.
- 286 funds tracked by Wall St. Rank held Innoviva as of Q1 2026.
Based on Everence Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.